AUD 0.05
(6.52%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -271.11 Thousand AUD | 116.26% |
2022 | 3.31 Million USD | 11.76% |
2021 | 2.96 Million AUD | 33.41% |
2020 | 2.22 Million AUD | 12.95% |
2019 | 1.96 Million AUD | 2592.41% |
2018 | -79 Thousand AUD | -156.83% |
2017 | 139 Thousand AUD | 115.67% |
2016 | -886.77 Thousand AUD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 Q2 | 1.08 Million USD | 0.37% |
2023 Q3 | 882.8 Thousand USD | -18.39% |
2023 FY | 7.17 Million AUD | 116.26% |
2023 Q4 | 832.63 Thousand USD | -5.68% |
2023 Q1 | 1.07 Million USD | 2387.13% |
2022 Q3 | 46.12 Thousand USD | -69.38% |
2022 Q4 | 43.33 Thousand USD | -6.05% |
2022 FY | 3.31 Million USD | 11.76% |
2022 Q2 | 150.63 Thousand USD | 0.0% |
2021 FY | 2.96 Million AUD | 33.41% |
2020 FY | 2.22 Million AUD | 12.95% |
2019 Q2 | 702.61 Thousand AUD | 0.0% |
2019 Q1 | 702.61 Thousand AUD | 0.0% |
2019 FY | 1.96 Million AUD | 2592.41% |
2018 Q1 | -27.98 Thousand AUD | 0.0% |
2018 FY | -79 Thousand AUD | -156.83% |
2018 Q4 | 702.61 Thousand AUD | 0.0% |
2018 Q2 | -27.98 Thousand AUD | 0.0% |
2017 Q1 | 44.55 Thousand AUD | 0.0% |
2017 Q2 | 44.55 Thousand AUD | 0.0% |
2017 Q4 | - AUD | 0.0% |
2017 FY | 139 Thousand AUD | 115.67% |
2016 Q2 | - AUD | 0.0% |
2016 Q1 | - AUD | 0.0% |
2016 Q4 | 44.55 Thousand AUD | 0.0% |
2016 FY | -886.77 Thousand AUD | 0.0% |
2015 Q4 | - AUD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
4DMedical Limited | 3.51 Million AUD | 107.708% |
Adherium Limited | -640.83 Thousand AUD | 57.693% |
Aroa Biosurgery Limited | 53.98 Million AUD | 100.502% |
Atomo Diagnostics Limited | 1.43 Million AUD | 118.871% |
Anteris Technologies Ltd | 2.51 Million AUD | 110.771% |
Control Bionics Limited | 3.67 Million AUD | 107.382% |
CardieX Limited | 10.1 Million AUD | 102.682% |
Compumedics Limited | 26.06 Million AUD | 101.04% |
Cochlear Limited | 1.69 Billion AUD | 100.016% |
CleanSpace Holdings Limited | 11.35 Million AUD | 102.387% |
Cyclopharm Limited | 4.49 Million AUD | 106.028% |
EMVision Medical Devices Ltd | 11.21 Million AUD | 102.417% |
Nova Eye Medical Limited | 20.19 Million AUD | 101.343% |
HeraMED Limited | -504.09 Thousand AUD | 46.217% |
Imricor Medical Systems, Inc. | -1.99 Million AUD | 86.396% |
ImpediMed Limited | 9 Million AUD | 103.011% |
InhaleRx Limited | 1.2 Million AUD | 122.517% |
LBT Innovations Limited | -2.91 Million AUD | 90.706% |
Micro-X Limited | 5.73 Million AUD | 104.726% |
Neurotech International Limited | -5867.00 AUD | -4521.033% |
OncoSil Medical Limited | 55.63 Thousand AUD | 587.338% |
PolyNovo Limited | 36.08 Million AUD | 100.751% |
Respiri Limited | 456.91 Thousand AUD | 159.336% |
SomnoMed Limited | 55.13 Million AUD | 100.492% |
Universal Biosensors, Inc. | 4.28 Million AUD | 106.327% |
Uscom Limited | 3.11 Million AUD | 108.702% |